Kissei Pharmaceutical Co Ltd banner

Intrinsic Value

The intrinsic value of Kissei Pharmaceutical Co Ltd (KSPHF) under the Base Case is 26.96 USD per share. Compared with the current market price of 24.5 USD, the stock appears Undervalued by 9% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

KSPHF Intrinsic Value
$26.96
Undervaluation 9%
Intrinsic Value
Price $24.5

KSPHF is valued in line with its history. A discount of this size has been typical over the past 5 years.

Monitor KSPHF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $21.57
Get notified when the price drops into your buy zone
Intrinsic Value $26.96
Current Price $24.5
Margin of Safety 20% $21.57
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to KSPHF

Fundamental Analysis

What Kissei Pharmaceutical Does

Pharmaceuticals Health Care

Kissei Pharmaceutical is a Japanese drug maker that discovers, develops, manufactures, and sells prescription medicines. Its main business is branded pharmaceuticals, especially treatments used in urology, kidney disease, and other specialist medical areas where patients often need long-term care.

Headquarters
Japan JP
Employees
1 778
IPO date
Dec 22, 1988
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Kissei Pharmaceutical Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one KSPHF stock?

The intrinsic value for Kissei Pharmaceutical Co Ltd (KSPHF) under the Base Case is 26.96 USD.

Is KSPHF stock undervalued or overvalued?

Compared with the current market price of 24.5 USD, the stock appears Undervalued by 9% .

Back to Top